RNAdvance Blood Performance and Data
Total RNA Isolation and Purification from Blood
The RNAdvance Blood system is a ribonucleic acid (RNA) isolation process built on SPRI paramagnetic bead-based technology. It enables purification of high-quality RNA from blood collected using PAXgene tubes. Total RNA extracted from PAXgene-preserved blood using the RNAdvance Blood kit is free of detectable genomic DNA (gDNA).
- Compatible with downstream gene expression analysis techniques:
- Produces high-quality RNA
- Efficient removal of gDNA and other contaminants
RNA Integrity Consistent Among Samples
RNAdvance Blood isolates RNA with high RIN scores.
Samples were from three different tubes taken from the same donor. RNA isolated from blood preserved in PAXgene tubes were run on an Agilent 6000 RNA Nano Assay using a Bioanalyzer (Agilent Technologies). The RIN scores averaged 9.4 with a σ2 of 0.4 for the 9 samples prepped.
RNAdvance Blood Isolates RNA at a Higher Yield Than Other Commercially Available Kits While Maintaining RNA Purity
RNA was extracted from blood preserved in PAXgene tubes according to manufacturer instructions.
(Left) Samples were quantified using the NanoDrop (Thermo Fisher Scientific). RNAdvance blood gave the highest RNA yield compared to other commercially available kits.
(Right) Samples were assessed for purity using the NanoDrop (Thermo Fisher Scientific). All kits isolated RNA with purity ratios suitable for downstream applications.
RNAdvance Eliminates DNA and PCR Inhibitors for Use in Downstream Applications
(Left) The amplification plot of RNA extracted using the RNAdvance blood kit. The purple and black lines represent six replicates that used 10 ng and 1 ng of extracted RNA, respectively, as inputs for qRT-PCR; the gray lines represent negative controls where no reverse transcriptase were added. The ΔRN is the normalized reporter value. The difference in the purple and black lines indicates that there are no PCR inhibitors in the final RNA samples, and the difference between the gray lines and the purple and black lines indicates the removal of DNA in the final RNA samples.
(Right) The amplification plot of 10 ng of RNA extracted using RNAdvance blood and two other suppliers. The RNAdvance blood has lower Ct values than the two other suppliers. PCR amplifiability was assessed via qRT-PCR using a primer set (forward primer 5´-ggacttcgagcaagagatgg-3´ and reverse primer 5´-agcactgtgttggcgtacag-3´) designed to span Exon 4 and 5 of the beta (β)-actin gene (ActB) to produce 327 base pair amplicons.
- Lyse PAXgene blood in Lysis Buffer and proteinase K
- Bind RNA to magnetic beads
- Separate magnetic beads from contaminants
- Wash magnetic beads with Wash Buffer and 70% ethanol to remove contaminants
- Treat samples with DNase I
- Rebind RNA to magnetic beads with Bind 2 Buffer
- Wash magnetic beads with 70% ethanol to remove contaminants
- Elute RNA from magnetic beads
- Transfer to new plate
Automation vs. Manual Timing
Estimated hands-on time and total time in hours required to perform 8, 24, 48 and 96 RNAdvance Blood RNA extractions. Extractions can be performed either manually or automated on a Biomek Workstation. The table represents automation times performed on a Biomek i7 Hybrid. The difference in time between manual and automation is indicated. NR=Not Recommended.
|Batch Size||8||Hands-on Time||1.00||0.25|
Products for Extracting RNA from Blood
|A35603||RNAdvance Blood Kit||50|
|A35605||RNAdvance Blood Kit||96|
|A35604||RNAdvance Blood Kit||384|
Not intended or validated for use in the diagnosis of disease or other conditions.
Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.